[go: up one dir, main page]

AU4728893A - Use of macrolide compounds for the treatment of skin diseases - Google Patents

Use of macrolide compounds for the treatment of skin diseases

Info

Publication number
AU4728893A
AU4728893A AU47288/93A AU4728893A AU4728893A AU 4728893 A AU4728893 A AU 4728893A AU 47288/93 A AU47288/93 A AU 47288/93A AU 4728893 A AU4728893 A AU 4728893A AU 4728893 A AU4728893 A AU 4728893A
Authority
AU
Australia
Prior art keywords
treatment
skin diseases
macrolide compounds
macrolide
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47288/93A
Inventor
Robert Victor Bundick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of AU4728893A publication Critical patent/AU4728893A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU47288/93A 1992-08-25 1993-08-20 Use of macrolide compounds for the treatment of skin diseases Abandoned AU4728893A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9218597 1992-08-25
GB929218597A GB9218597D0 (en) 1992-08-25 1992-08-25 Novel method of treatment
PCT/GB1993/001770 WO1994004149A1 (en) 1992-08-25 1993-08-20 Use of macrolide compounds for the treatment of skin diseases

Publications (1)

Publication Number Publication Date
AU4728893A true AU4728893A (en) 1994-03-15

Family

ID=10721299

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47288/93A Abandoned AU4728893A (en) 1992-08-25 1993-08-20 Use of macrolide compounds for the treatment of skin diseases

Country Status (6)

Country Link
AU (1) AU4728893A (en)
GB (1) GB9218597D0 (en)
IL (1) IL106764A0 (en)
MX (1) MX9305151A (en)
WO (1) WO1994004149A1 (en)
ZA (1) ZA936136B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2019117548A (en) 2016-11-10 2020-12-10 Новартис Аг BMP AMPLIFIERS
EP4161510A4 (en) * 2020-06-09 2024-08-07 Uniquest Pty Ltd COMPOUND FOR THE PREVENTION OR TREATMENT OF SKIN CANCER OR SKIN PRECANCER

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK175235B1 (en) * 1987-11-09 2004-07-19 Novartis Ag New use of azatricyclo derivatives and pharmaceutical compositions containing them
JP2799208B2 (en) * 1987-12-09 1998-09-17 フアイソンズ・ピーエルシー Macrocyclic compound
GR1001225B (en) * 1989-09-14 1993-06-30 Fisons Plc Novel macrocyclic compositions and new application method thereof

Also Published As

Publication number Publication date
WO1994004149A1 (en) 1994-03-03
MX9305151A (en) 1994-05-31
GB9218597D0 (en) 1992-10-14
ZA936136B (en) 1994-02-21
IL106764A0 (en) 1993-12-08

Similar Documents

Publication Publication Date Title
AU2845492A (en) Dipyridamole for the treatment of proliferative diseases
AU1966992A (en) Skin treatment system
AU2159092A (en) Use of lysophosphate acids for the treatment of skin wrinkles
AU7746291A (en) Device for treatment of undesired skin disfigurements
AU6273796A (en) Nucleotide analogues for topical treatment of proliferative disease of the skin
HU9300536D0 (en) Compounds of medical effect
AU4048295A (en) Peptide medicaments for the treatment of disease
IL129144A0 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
IL101410A0 (en) Formulation for the treatment of cancer
AU7310896A (en) Use of nitroflavonoids for the treatment of anxiety
AU2806692A (en) Medicament for the treatment of anxiety
AU9173191A (en) Medicaments for the treatment of papillomavirus diseases
IL115320A0 (en) Retinoyloxy (substituted) methyl butyrates useful for the treatment of cancer and other proliferative diseases
AU3455393A (en) Preparation for skin use
AU5340594A (en) Skin treatment
AU6147296A (en) Therapeutic use of acetazolamide for the treatment of brain edema
AU4081393A (en) Medicaments for the treatment of anxiety
AU8185491A (en) Treatment of disease
AU5699396A (en) Compositions for the treatment of skin conditions
AU3434489A (en) Skin treatment formulations
AU5252793A (en) Therapeutic for gram-positive diseases of aquatic species
AU4728893A (en) Use of macrolide compounds for the treatment of skin diseases
GB9217124D0 (en) Medical treatment
AU5018893A (en) Substituted hydrindanes for the treatment of angiogenesis-dependent diseases
GB9021113D0 (en) New use of macrolide compounds for active oxygen-mediated diseases